Hospitali ya Kitaifa ya Kenyatta iliyoko jijini Nairobi, ni Hospitali kongwe zaidi nchini Kenya. Ilianzishwa mwaka wa 1901 na uwezo wa vitanda takribani 40 kama Native Civil Hospital, ilibadilishwa jina na kuitwa King George VI mwaka 1952.

During the past decade, Kenyatta National Hospital, University of Nairobi conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kenyatta National Hospital, University of Nairobi" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Bill and Melinda Gates Foundation" with 1 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator and "University of Cape Town" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Kenyatta National Hospital, University of Nairobi" are "HIV Infections" (2 trials), "HIV-1 Infections" (1 trials) and "Rheumatic Heart Disease" (1 trials). Many other conditions were trialed in "Kenyatta National Hospital, University of Nairobi" in a lesser frequency.

Most popular intervention types in "Kenyatta National Hospital, University of Nairobi" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "ABC/ ddI or TDF / NVP or EFV (abacavir / didanosine or tenofovir / nevirapine or efavirenz)" (1 trials), "ABC/3TC/NVP (abacavir/lamivudine/nevirapine)" (1 trials), "AZT/3TC/ABC (zidovudine/lamivudine/abacavir)" (1 trials), "AZT/3TC/NVP (zidovudine/lamivudine/nevirapine)" (1 trials) and "Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kenyatta National Hospital, University of Nairobi" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Kenyatta National Hospital, University of Nairobi". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kenyatta National Hospital, University of Nairobi, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kenyatta National Hospital, University of Nairobi, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".